Muse® by Interaxon, a prominent player in brain health and neurotechnology, has introduced Alpha Peak, a new metric designed to assess cognitive performance.

This metric is the first in a series of advanced brain health tools that provide users with personalized insights into cognitive function through an intuitive score, aiming to boost mental fitness.

As individuals age, cognitive decline becomes a significant concern, and measuring it has traditionally been challenging.

Research indicates that cognitive functions such as memory, executive functions, processing speed, and reasoning can begin to deteriorate as early as the 30s. Furthermore, mild cognitive impairment (MCI) affects 10-20% of adults over 65, with the potential to progress to more severe cognitive issues if not managed effectively.

Alpha Peak: The Brain's HRV Equivalent

Alpha Peak is designed to function like heart rate variability (HRV), offering insights into the brain’s aging process and enabling users to manage their cognitive health.

Alpha peak frequency (APF) changes with age: it increases during childhood, peaks in early adulthood, and then declines. This trend reflects its association with cognitive development and aging.

A 2016 study involving over 6,000 participants using Muse devices found a significant correlation between APF and cognitive performance, including overall cognitive health, processing speed, and memory.

With Muse’s mEEG devices, users can measure their APF after biofeedback sessions to obtain a cognitive performance score and receive tailored recommendations for optimizing alpha wave activity.

After completing several sessions, users establish a personalized baseline and receive a graph indicating whether their Alpha Peak is within, below, or above this baseline.

Users can also monitor lifestyle factors such as diet, exercise, and sleep, correlating these changes with their Alpha Peak score and receiving customized suggestions to improve their habits.

Muse's commitment to brain health extends into various research areas:

• AI-Powered Sleep Diagnostics & Therapeutics: Muse’s mEEG headbands, featuring advanced sleep staging algorithms, provide superior precision and scalability compared to traditional methods. This advanced analysis is now more accessible to researchers and clinicians, offering deeper insights into sleep beyond conventional staging.
• Brain Age & Cognitive Decline: Muse has developed a "Brain Age Score" to track brain health relative to chronological age, offering actionable insights for maintaining and improving cognitive health.
• Mild Cognitive Decline (MCI) Research: In 2024, Muse will conduct a major study on MCI in collaboration with the University of Victoria. This research aims to enhance MCI diagnosis and monitoring using Muse devices for at-home brain assessments, potentially revolutionizing early intervention strategies and offering new hope for individuals at risk of cognitive decline.

Source: businesswire.com

Report Abuse